Propoven 2% May Join Your Sedative List Due to COVID-19

A new double-strength propofol may hit your shelves...to help meet demand during the COVID-19 pandemic.

It’s because more patients are requiring sedation due to mechanical ventilation for COVID-19...and regular propofol and other sedatives (midazolam, etc) have been in short supply.

“Double-strength” means the product is propofol 2%, or 20 mg/mL...compared to regular propofol, which is 1%, or 10 mg/mL.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote